Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-03-03 4:30 pm Sale | 13D | Marker Therapeutics, Inc. MRKR | Aisling Capital IV LP | 464,285 5.46% | -3,035,715 (-86.73%) | View |
| 2021-03-26 10:38 am Purchase | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 14,464,285 17.4% | 14,464,285 (New Position) | View |
| 2021-03-23 7:45 pm Sale | 13D | Marker Therapeutics, Inc. MRKR | Leen Ann M. | 2,415,842 2.89% | -300,000 (-11.05%) | View |
| 2021-03-15 4:45 pm Sale | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 3,966,668 5% | -500,000 (-11.19%) | View |
| 2020-11-13 4:14 pm Sale | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 4,466,668 9.2% | -416,667 (-8.53%) | View |
| 2020-06-18 4:42 pm Sale | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 4,883,335 10.3% | -416,667 (-7.86%) | View |
| 2020-02-20 4:24 pm Unchanged | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 5,300,002 11.2% | 0 (Unchanged) | View |
| 2020-02-14 4:27 pm Sale | 13G | Marker Therapeutics, Inc. MRKR | PERCEPTIVE ADVISORS LLC | 0 0% | -3,500,000 (Position Closed) | View |
| 2019-02-14 4:36 pm Purchase | 13G | Marker Therapeutics, Inc. MRKR | PERCEPTIVE ADVISORS LLC | 3,500,000 7.5% | 3,500,000 (New Position) | View |
| 2019-02-14 11:21 am Purchase | 13D | Marker Therapeutics, Inc. MRKR | Vera Juan | 2,715,842 5.9% | 2,715,842 (New Position) | View |
| 2019-02-14 11:19 am Purchase | 13D | Marker Therapeutics, Inc. MRKR | Leen Ann M. | 2,715,842 5.9% | 2,715,842 (New Position) | View |
| 2019-02-14 11:15 am Purchase | 13D | Marker Therapeutics, Inc. MRKR | Wilson John Robert | 8,261,853 17.37% | 8,261,853 (New Position) | View |
| 2019-02-04 09:29 am Sale | 13G | Marker Therapeutics, Inc. MRKR | Brio Capital Master Fund Ltd. | 237,496 0.05% | -560,548 (-70.24%) | View |
| 2018-11-08 11:22 am Unchanged | 13D | Marker Therapeutics, Inc. MRKR | Eastern Capital LTD | 5,300,002 11.3% | 0 (Unchanged) | View |
| 2018-10-25 4:13 pm Purchase | 13D | Marker Therapeutics, Inc. MRKR | New Enterprise Associates 16 L.P. | 8,750,000 17.8% | 8,750,000 (New Position) | View |
| 2018-10-19 5:09 pm Purchase | 13D | Marker Therapeutics, Inc. MRKR | Aisling Capital IV LP | 3,500,000 7.7% | 3,500,000 (New Position) | View |